Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

VBI Vaccines Inc. (VBIV)

3.03 0 (0%)

06-22 16:00

Open:

3.02

Pre. Close:

3.03

High:

3.19

Low:

2.901

Volume:

906,426

Market Cap:

195M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

3.193 - 3.215

3.215 - 3.233

Low:

2.861 - 2.883

2.883 - 2.9

Close:

3 - 3.036

3.036 - 3.063

Technical analysis  (as of: 2018-06-22 4:35:31 PM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 4.15     One year: 4.61

Support:

Support1: 2.90    Support2: 2.41

Resistance:

Resistance1: 3.55    Resistance2: 3.95

Pivot:

3.25

Moving Averages:

MA(5): 3.13     MA(20): 3.20

MA(100): 3.49     MA(250): 3.85

MACD:

MACD(12,26): -0.01     Signal(12,26,9): 0.02

%K %D:

%K(14,3): 16.40     %D(3): 21.68

RSI:

RSI(14): 43.19

52-Week:

High: 5.1  Low: 2.82  Change(%): -29.4

Average Vol(K):

3-Month: 24166  10-Days 52042

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
VBIV has closed above bottom band by 30.8%. Bollinger Bands are 83.3% wider than normal. The large width of the bands suggest high volatility as compared to VBIV's normal range. The bands have been in this wide range for 7 bars. This is a sign that the current trend might continue.

Headline News

2018-05-27T00:21:17-04:00
Reader Inquiry: VBI Vaccines´ CEO Is Buying Shares, Should You?

2018-05-11T13:34:19-04:00
VBI Vaccines (VBIV) CMV Vaccine VBI - 1501A Final Phase I Data - Slideshow

2018-05-10T08:53:27-04:00
VBI's CMV vaccine candidate shows positive effect in early-stage study; shares ahead 11% premarket

2018-05-01T08:21:06-04:00
VBI Vaccines misses by $0.03

2018-04-13T01:03:46-04:00
Institutional Top Ideas Series: DAFNA Capital Management

2018-03-07T07:45:00-05:00
Pretenders And Ghosts: Stealth Promotion Network Exploits Financial Sites To Tout Stocks

2018-01-18T08:00:00-05:00
Your Daily Pharma Scoop: Juno Surges On Takeover Rumors, AEterna Zentaris Achieves Another Milestone, Spark Granted ODD

2018-01-17T09:29:32-05:00
Dosing underway in early-stage study of VBI Vaccines' VBI-1901 in GBM

Financial Analysis

Growth

NA

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

NA

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

NA

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  0

Industry:  0

Shares Out. (M)

64.22

Shares Float (M)

63.47

% Held by Insiders

% Held by Institutions

33.00

Shares Short (K)

1029

Shares Short Prior Month (K)

688

Stock Financials

EPS

EPS Est. Current Year

-0.890

EPS Est. Next Year

-1.010

EPS Est. Next Quarter

-0.240

Forward EPS

-0.971

Book Value (p.s.)

2.270

PEG Ratio

Profit Margin

Operating Margin

-4275.14

Return on Assets (ttm)

-34.5

Return on Equity (ttm)

-43.9

Qtrly Rev. Growth

46.7

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

Qtrly Earnings Growth

Operating Cash Flow (M)

-31.38

Levered Free Cash Flow (M)

-17.96

atoplab.com

Valuation

P/E

P/E Growth Ratio

P/BV

1.33

P/S

9729330176.00

P/CF

-6.20

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

2012-12-28

Ex-Dividend Date

2012-02-04

Forward Dividend

Last Split Date

2016-05-02

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.